Pictet Asset Management (UK)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$7.16M Buy
57,563
+263
+0.5% +$31.4K 0.01% 772
2021
Q1
$7.55M Sell
57,300
-7,700
-12% -$1.05M 0.01% 737
2020
Q4
$8.61M Buy
65,000
+9,500
+17% +$1.15M 0.01% 668
2020
Q3
$5.66M Sell
55,500
-4,000
-7% -$345K 0.01% 693
2020
Q2
$5.17M Sell
59,500
-107,769
-64% -$8.61M 0.01% 676
2020
Q1
$9.7M Buy
167,269
+37,415
+29% +$3.04M 0.02% 485
2019
Q4
$12M Buy
129,854
+84,154
+184% +$7.4M 0.02% 539
2019
Q3
$4.13M Sell
45,700
-180,717
-80% -$20.6M 0.01% 743
2019
Q2
$26.7M Buy
226,417
+62,114
+38% +$6.26M 0.06% 334
2019
Q1
$14.2M Buy
+164,303
New +$14M 0.03% 464

Other funds holding EXAS

Pictet Asset Management (UK)'s EXAS Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Exact Sciences (EXAS) stake by 0.46% in Q2 2021, buying an estimated $31.4K and bringing the position to 57,563 shares worth $7.16M. The position accounts for 0.01% of the portfolio, ranked #772.

Pictet Asset Management (UK) first reported a position in EXAS in Q1 2019 and has held it in 10 quarters since. The position peaked at $26.7M in Q2 2019. 622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Pictet Asset Management (UK) held 57,563 shares of Exact Sciences worth $7.16M as of Q2 2021.
  • Pictet Asset Management (UK) bought 263 Exact Sciences shares in Q2 2021, an estimated $31.4K.
  • Exact Sciences made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #772 holding.
  • Pictet Asset Management (UK) first reported a position in Exact Sciences in Q1 2019 and has held it in 10 quarters since.
  • Pictet Asset Management (UK)'s Exact Sciences position peaked at $26.7M in Q2 2019.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.